Concurrent vs. Sequential Sipuleucel-T & Abiraterone Treatment in Men With Metastatic Castrate Resistant Prostate Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Robert Israel, MD
Valeant Pharmaceuticals North America LLC
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
21 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Moores Ucsd Cancer Center
La Jolla, California, United States
- Ucsd Medical Center - la Jolla
La Jolla, California, United States
- Cancer Center Oncology Medical Group
La Mesa, California, United States
- Medical Oncology Associates - Sd
San Diego, California, United States
- Sharp Rees-Stealy
San Diego, California, United States
- Ucsd Medical Center - Hillcrest
San Diego, California, United States
- Ucsf Helen Diller Family Comprehensive Cancer Center
San Francisco, California, United States
- the Urology Center of Colorado
Denver, Colorado, United States
- Georgetown University Medical Center - Lombardi Cancer Center
Washington D.C., District of Columbia, United States
- Indiana University
Indianapolis, Indiana, United States
- Mid Atlantic Urology Associates, Mid Atlantic Clinical Research
Greenbelt, Maryland, United States
- Gu Research Center, Llc
Omaha, Nebraska, United States
- Nyu Clinical Cancer Center, Nyu Langone Medical Center
New York, New York, United States
- the Mount Sinai Medical Center
New York, New York, United States
- Associated Medical Professionals of Ny, Pllc
Oneida, New York, United States
- Associated Medical Professionals of New York, Pllc
Syracuse, New York, United States
- Providence Cancer Center Oncology and Hematology Care
Portland, Oregon, United States
- Carolina Urologic Research Center
Myrtle Beach, South Carolina, United States
- Urology Associates, P.C.
Nashville, Tennessee, United States
- Urology of Virginia
Virginia Beach, Virginia, United States
- Virginia Mason Medical Center
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2011
- Primary completion
- 31 May 2016
- Completion
- 30 Jun 2016
- Last update posted
- 19 Mar 2019
- Registered enrollment
- 69
- Registry id
- NCT01487863
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.